Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TIROFIBAN HYDROCHLORIDE
(1998)
Small molecule
Integrin alpha-IIb/beta-3 inhibitor
INJECTION
Approved
Myocardial Infarction
TIROFIBAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
6H925F8O5J
Molecule Type:
Small molecule
Molecular Formula:
C22H39ClN2O6S
Molecular Weight:
495.08
AlogP:
2.95
PSA:
104.73
HBD:
3.0
HBA:
#RotB:
14.0
Source:
CANDESARTAN CILEXETIL
(1998)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Angina Pectoris; Cardiovascular Diseases; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke
CANDESARTAN CILEXETIL
×
Maximum Phase:
4
First Approval:
1998
UNII:
R85M2X0D68
Molecule Type:
Small molecule
Molecular Formula:
C33H34N6O6
Molecular Weight:
610.67
AlogP:
6.32
PSA:
143.34
HBD:
1.0
HBA:
#RotB:
10.0
Source:
SEVELAMER HYDROCHLORIDE
(1998)
Small molecule
Phosphate sequestering agent
ORAL
Approved
Unknown
SEVELAMER HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
GLS2PGI8QG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOLTERODINE TARTRATE
(1998)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
TOLTERODINE TARTRATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
5T619TQR3R
Molecule Type:
Small molecule
Molecular Formula:
C26H37NO7
Molecular Weight:
475.58
AlogP:
5.34
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TOLCAPONE
(1998)
Small molecule
Catechol O-methyltransferase inhibitor
ORAL
Approved
Liver Failure; Parkinson Disease
TOLCAPONE
×
Maximum Phase:
4
First Approval:
1998
UNII:
CIF6334OLY
Molecule Type:
Small molecule
Molecular Formula:
C14H11NO5
Molecular Weight:
273.24
AlogP:
2.55
PSA:
100.67
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LEFLUNOMIDE
(1998)
Small molecule
Dihydroorotate dehydrogenase inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases; Multiple Sclerosis
LEFLUNOMIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
G162GK9U4W
Molecule Type:
Small molecule
Molecular Formula:
C12H9F3N2O2
Molecular Weight:
270.21
AlogP:
3.25
PSA:
55.13
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LOTEPREDNOL ETABONATE
(1998)
Small molecule
Glucocorticoid receptor agonist
OPHTHALMIC
Approved
Conjunctivitis, Allergic; Dry Eye Syndromes; Eye Diseases; Inflammation; Uveitis, Anterior
LOTEPREDNOL ETABONATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
YEH1EZ96K6
Molecule Type:
Small molecule
Molecular Formula:
C24H31ClO7
Molecular Weight:
466.96
AlogP:
3.92
PSA:
99.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SIMETHICONE-CELLULOSE
(1998)
Small molecule
Unknown
ORAL
Approved
Unknown
SIMETHICONE-CELLULOSE
×
Maximum Phase:
4
First Approval:
1998
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABACAVIR
(1998)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
ABACAVIR
×
Maximum Phase:
4
First Approval:
1998
UNII:
WR2TIP26VS
Molecule Type:
Small molecule
Molecular Formula:
C14H18N6O
Molecular Weight:
286.34
AlogP:
1.09
PSA:
101.88
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TOLTERODINE
(1998)
Small molecule
Unknown
Unknown
Approved
Polyuria; Urinary Incontinence
TOLTERODINE
×
Maximum Phase:
4
First Approval:
1998
UNII:
WHE7A56U7K
Molecule Type:
Small molecule
Molecular Formula:
C22H31NO
Molecular Weight:
325.5
AlogP:
5.34
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TELMISARTAN
(1998)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Hypertension; Myocardial Infarction; Stroke
TELMISARTAN
×
Maximum Phase:
4
First Approval:
1998
UNII:
U5SYW473RQ
Molecule Type:
Small molecule
Molecular Formula:
C33H30N4O2
Molecular Weight:
514.63
AlogP:
7.26
PSA:
72.94
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CITALOPRAM
(1998)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
CITALOPRAM
×
Maximum Phase:
4
First Approval:
1998
UNII:
0DHU5B8D6V
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN2O
Molecular Weight:
324.4
AlogP:
3.81
PSA:
36.26
HBD:
0.0
HBA:
#RotB:
5.0
Source:
SILDENAFIL CITRATE
(1998)
Small molecule
Phosphodiesterase 5A inhibitor
INTRAVENOUS; ORAL
Approved
Connective Tissue Diseases; Erectile Dysfunction; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Pulmonary Arterial Hypertension
SILDENAFIL CITRATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
BW9B0ZE037
Molecule Type:
Small molecule
Molecular Formula:
C28H38N6O11S
Molecular Weight:
666.71
AlogP:
1.61
PSA:
113.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
NARATRIPTAN HYDROCHLORIDE
(1998)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
NARATRIPTAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
10X8X4P12Z
Molecule Type:
Small molecule
Molecular Formula:
C17H26ClN3O2S
Molecular Weight:
371.93
AlogP:
2.07
PSA:
65.2
HBD:
2.0
HBA:
#RotB:
5.0
Source:
RIFAPENTINE
(1998)
Small molecule
Bacterial DNA-directed RNA polymerase inhibitor
ORAL
Approved
Tuberculosis
RIFAPENTINE
×
Maximum Phase:
4
First Approval:
1998
UNII:
XJM390A33U
Molecule Type:
Small molecule
Molecular Formula:
C47H64N4O12
Molecular Weight:
877.04
AlogP:
5.65
PSA:
220.15
HBD:
6.0
HBA:
#RotB:
5.0
Source:
PARICALCITOL
(1998)
Small molecule
Vitamin D receptor agonist
INJECTION; INTRAVENOUS; ORAL
Approved
Hyperparathyroidism, Secondary; Parathyroid Diseases; Renal Insufficiency, Chronic
PARICALCITOL
×
Maximum Phase:
4
First Approval:
1998
UNII:
6702D36OG5
Molecule Type:
Small molecule
Molecular Formula:
C27H44O3
Molecular Weight:
416.65
AlogP:
5.56
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
5.0
Source:
RISEDRONIC ACID
(1998)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
RISEDRONIC ACID
×
Maximum Phase:
4
First Approval:
1998
UNII:
KM2Z91756Z
Molecule Type:
Small molecule
Molecular Formula:
C7H11NO7P2
Molecular Weight:
283.11
AlogP:
-0.37
PSA:
148.18
HBD:
5.0
HBA:
#RotB:
4.0
Source:
ZALEPLON
(1999)
Small molecule
GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator
ORAL
Approved
Sleep Initiation and Maintenance Disorders
ZALEPLON
×
Maximum Phase:
4
First Approval:
1999
UNII:
S62U433RMH
Molecule Type:
Small molecule
Molecular Formula:
C17H15N5O
Molecular Weight:
305.34
AlogP:
2.64
PSA:
74.29
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LEVOSALBUTAMOL
(1999)
Small molecule
Unknown
Unknown
Approved
Unknown
LEVOSALBUTAMOL
×
Maximum Phase:
4
First Approval:
1999
UNII:
EDN2NBH5SS
Molecule Type:
Small molecule
Molecular Formula:
C13H21NO3
Molecular Weight:
239.31
AlogP:
1.31
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
4.0
Source:
RABEPRAZOLE
(1999)
Small molecule
Unknown
Unknown
Approved
Gastroesophageal Reflux; Peptic Ulcer
RABEPRAZOLE
×
Maximum Phase:
4
First Approval:
1999
UNII:
32828355LL
Molecule Type:
Small molecule
Molecular Formula:
C18H21N3O3S
Molecular Weight:
359.45
AlogP:
2.99
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ROFECOXIB
(1999)
Small molecule
Cyclooxygenase-2 inhibitor
ORAL
Approved
Rheumatic Diseases
ROFECOXIB
×
Maximum Phase:
4
First Approval:
1999
UNII:
0QTW8Z7MCR
Molecule Type:
Small molecule
Molecular Formula:
C17H14O4S
Molecular Weight:
314.36
AlogP:
2.56
PSA:
60.44
HBD:
0.0
HBA:
#RotB:
3.0
Source:
DOXERCALCIFEROL
(1999)
Small molecule
Vitamin D receptor agonist
INJECTION; ORAL
Approved
Hyperparathyroidism, Secondary; Parathyroid Diseases; Renal Insufficiency, Chronic
DOXERCALCIFEROL
×
Maximum Phase:
4
First Approval:
1999
UNII:
3DIZ9LF5Y9
Molecule Type:
Small molecule
Molecular Formula:
C28H44O2
Molecular Weight:
412.66
AlogP:
6.61
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
5.0
Source:
LEVOBUPIVACAINE
(1999)
Small molecule
Unknown
Unknown
Approved
Unknown
LEVOBUPIVACAINE
×
Maximum Phase:
4
First Approval:
1999
UNII:
A5H73K9U3W
Molecule Type:
Small molecule
Molecular Formula:
C18H28N2O
Molecular Weight:
288.44
AlogP:
3.9
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LEVALBUTEROL HYDROCHLORIDE
(1999)
Small molecule
Beta-2 adrenergic receptor agonist
INHALATION
Approved
Bronchial Spasm
LEVALBUTEROL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
WDQ1526QJM
Molecule Type:
Small molecule
Molecular Formula:
C13H22ClNO3
Molecular Weight:
275.78
AlogP:
1.31
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
4.0
Source:
EPIRUBICIN
(1999)
Small molecule
Unknown
Unknown
Approved
Neoplasms
EPIRUBICIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
3Z8479ZZ5X
Molecule Type:
Small molecule
Molecular Formula:
C27H29NO11
Molecular Weight:
543.53
AlogP:
0.0
PSA:
206.07
HBD:
6.0
HBA:
#RotB:
5.0
Source:
GATIFLOXACIN
(1999)
Small molecule
DNA gyrase inhibitor
OPHTHALMIC
Approved
Bacterial Infections; Conjunctivitis, Bacterial; Eye Infections; Infections
GATIFLOXACIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
L4618BD7KJ
Molecule Type:
Small molecule
Molecular Formula:
C19H22FN3O4
Molecular Weight:
375.4
AlogP:
1.98
PSA:
83.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CILOSTAZOL
(1999)
Small molecule
Phosphodiesterase 3A inhibitor
ORAL
Approved
Thrombosis
CILOSTAZOL
×
Maximum Phase:
4
First Approval:
1999
UNII:
N7Z035406B
Molecule Type:
Small molecule
Molecular Formula:
C20H27N5O2
Molecular Weight:
369.47
AlogP:
3.46
PSA:
81.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
LEVOBUPIVACAINE HYDROCHLORIDE
(1999)
Small molecule
Sodium channel protein type IV alpha subunit blocker
Unknown
Approved
Unknown
LEVOBUPIVACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
J998RDZ51I
Molecule Type:
Small molecule
Molecular Formula:
C18H29ClN2O
Molecular Weight:
324.9
AlogP:
3.9
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GADOVERSETAMIDE
(1999)
Small molecule
Diagnostic agent
INJECTION
Approved
Unknown
GADOVERSETAMIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
RLM74T3Z9D
Molecule Type:
Small molecule
Molecular Formula:
C20H34GdN5O10
Molecular Weight:
661.77
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RABEPRAZOLE SODIUM
(1999)
Small molecule
Potassium-transporting ATPase inhibitor
Unknown
Approved
Duodenal Ulcer; Gastroesophageal Reflux; Zollinger-Ellison Syndrome
RABEPRAZOLE SODIUM
×
Maximum Phase:
4
First Approval:
1999
UNII:
3L36P16U4R
Molecule Type:
Small molecule
Molecular Formula:
C18H20N3NaO3S
Molecular Weight:
381.43
AlogP:
2.99
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DEXMEDETOMIDINE HYDROCHLORIDE
(1999)
Small molecule
Adrenergic receptor alpha-2 agonist
INJECTION; INTRAVENOUS
Approved
Unknown
DEXMEDETOMIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
1018WH7F9I
Molecule Type:
Small molecule
Molecular Formula:
C13H17ClN2
Molecular Weight:
236.75
AlogP:
3.18
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MOXIFLOXACIN HYDROCHLORIDE
(1999)
Small molecule
Bacterial DNA gyrase inhibitor
INTRAVENOUS; OPHTHALMIC; ORAL
Approved
Bronchitis, Chronic; Conjunctivitis, Bacterial; Infections; Pneumonia; Sinusitis
MOXIFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
C53598599T
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClFN3O4
Molecular Weight:
437.9
AlogP:
2.37
PSA:
83.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ALITRETINOIN
(1999)
Small molecule
Retinoid receptor agonist
TOPICAL
Approved
Eczema; Neoplasms
ALITRETINOIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
1UA8E65KDZ
Molecule Type:
Small molecule
Molecular Formula:
C20H28O2
Molecular Weight:
300.44
AlogP:
5.6
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
EXEMESTANE
(1999)
Small molecule
Cytochrome P450 19A1 inhibitor
Unknown
Approved
Breast Neoplasms; Neoplasms
EXEMESTANE
×
Maximum Phase:
4
First Approval:
1999
UNII:
NY22HMQ4BX
Molecule Type:
Small molecule
Molecular Formula:
C20H24O2
Molecular Weight:
296.41
AlogP:
4.03
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
0.0
Source:
KETOTIFEN
(1999)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Hypersensitivity
KETOTIFEN
×
Maximum Phase:
4
First Approval:
1999
UNII:
X49220T18G
Molecule Type:
Small molecule
Molecular Formula:
C19H19NOS
Molecular Weight:
309.43
AlogP:
4.01
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
0.0
Source:
KETOTIFEN FUMARATE
(1999)
Small molecule
Histamine H1 receptor antagonist
OPHTHALMIC
Approved
Unknown
KETOTIFEN FUMARATE
×
Maximum Phase:
4
First Approval:
1999
UNII:
HBD503WORO
Molecule Type:
Small molecule
Molecular Formula:
C23H23NO5S
Molecular Weight:
425.51
AlogP:
4.01
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
0.0
Source:
1
2
…
48
49
50
51
52
53
54
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA